Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Viking Holdings Ltd Ordinary Shares (VIK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Viking Holdings Ltd Ordinary Shares — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.52 (market cap $5.85B), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.29B). The key difference: Viking Holdings Ltd Ordinary Shares is far larger — about 6.2× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Viking Holdings Ltd Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.
| IOVA | VIK | |
|---|---|---|
Market Cap | $5.85B | $36.29B |
Volume | 14,517,176 | 2,522,956 |
Sector | Health | Consumer Cyclical |
52-Week High | $14.82 | $108.26 |
52-Week Low | $1.81 | $57.08 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.78B | $38.67B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Viking Holdings Ltd Ordinary Shares
Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.
Read more on VIK →
